Table 3.
Trial | QTL | Position (cM) | Peak marker | LOD | Effect | R 2 (%) | Total R 2 (%) |
---|---|---|---|---|---|---|---|
USDA03 | 2B | 14 | Xwmc317 | 3.9 | 5.9 | 5.5 | 56.0 |
7D | 1 | wPt-2565 | 43.5 | 16.2 | 43.5 | ||
USU03 | 1A | 74 | Xcfa2129 | 10.6 | 7.7 | 13.7 | 64.7 |
2B | 15.2 | Xwmc317 | 3.8 | 5.8 | 4.4 | ||
7D | 1 | wPt-2565 | 28.1 | 17.7 | 48.8 | ||
1A × 7D | – | – | 4.1 | 5.2 | 4.9 | ||
USU04 | 1A | 76 | Xcfa2129 | 8.1 | 11.0 | 10.9 | 61.7 |
7D | 1 | wPt-2565 | 29.0 | 25.7 | 55.6 | ||
USU11 | 1A | 76 | Xcfa2129 | 10.7 | 7.2 | 15.0 | 58.6 |
2B | 13 | Xwmc317 | 2.3 | 3.8 | 2.3 | ||
7D | 1 | wPt-2565 | 23.7 | 13.2 | 40.7 | ||
1A × 7D | – | – | 3.0 | 3.8 | 3.8 | ||
BLUP | 1A | 74.3 | Xcfa2129 | 9.8 | 6.1 | 9.9 | 69.9 |
2B | 13 | Xwmc317 | 3.7 | 5.0 | 3.7 | ||
7D | 1 | wPt-2565 | 35.2 | 16.5 | 53.4 | ||
1A × 7D | – | – | 2.7 | 3.2 | 2.4 |